Drugs

Treatment for Congestive Heart Failure scPharmaceuticals Inc. Receives Complete Response Letter from FDA for Furoscix BURLINGTON, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today
0 Comments
Treatment for Acne Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Twyneo for the Treatment of Acne Vulgaris NESS ZIONA, Israel, Dec. 07, 2020 (GLOBE NEWSWIRE) – Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced
0 Comments
WASHINGTON, Dec. 1, 2020 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved Hetlioz (tasimelteon) capsule and liquid formulations for the treatment of adults and children, respectively, with nighttime sleep disturbances associated with Smith-Magenis Syndrome (SMS). SMS is a rare neurodevelopmental disorder, a defining
0 Comments
New research investigates the benefits of blackcurrant and the potential of this sweet-and-sour fruit to regulate blood sugar. Rich in a variety of different vitamins, antioxidants, and minerals, including vitamin C, folate, and potassium, fruit is great for the body and can produce a variety of health benefits.  This can help the body repair injuries,
0 Comments
Researchers in a recent study confirms the link between the use of hormone replacement therapy and cancer. What is hormone replacement therapy? Hormone replacement therapy (HRT) is prescribed to relieve the symptoms of menopause (hot flashes, fatigue) and reduce bone losses. There are two main types of HRT: Combination HRT contains the hormones estrogen and
0 Comments
Treatment for Hypogonadism — Male Lipocine Announces Tentative Approval of TLANDO SALT LAKE CITY, Dec. 8, 2020 /PRNewswire/ — Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the U.S. Food and Drug Administration (“FDA”) has granted tentative approval to TLANDO, its oral testosterone product for testosterone replacement therapy (“TRT”)
0 Comments
South San Francisco, CA — December 1, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License Application (sBLA) for Xolair ® (omalizumab) for the add-on maintenance treatment of nasal polyps in adult patients 18 years of
0 Comments
December 9, 2020 Audience: Consumer, Health Professional, Pharmacy December 9, 2020 — Torrent Pharmaceuticals Limited is voluntarily recalling one lot of Anagrelide Capsules, USP to the consumer level due to dissolution test failure detected during routine quality testing. Failed dissolution can result in a slower rate and extent of drug release leading to less anagrelide
0 Comments
A recent study explores the link between high blood pressure and brain damage in the elderly. Aging is associated with an overall decline in normal body functioning. Researchers are currently interested in investigating a type of brain damage named “white matter hyperintensities”, or WMH. The condition can be noticed on MRI brain scans of patients
0 Comments
odevixibat Treatment for Progressive Familial Intrahepatic Cholestasis (PFIC) Albireo Submits for U.S. FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC BOSTON, Dec. 08, 2020 (GLOBE NEWSWIRE) – Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced it has submitted a New Drug Application (NDA) to the U.S. Food and
0 Comments
FDA Approves Gallium 68 PSMA-11 as the First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer December 01, 2020 — Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) – the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with
0 Comments
December 9, 2020 Audience: Consumer, Health Professional, Pharmacy December 9, 2020 — AvKARE, Pulaski, TN is voluntarily recalling one lot of Sildenafil 100 mg tablets and one lot of Trazodone 100mg tablets to the consumer level. These products have been recalled due to a product mix-up of the listed two separate products inadvertently packaged together
0 Comments
Complementary and alternative medicine (CAM) is rising in use within healthcare settings in Western countries as either a replacement for or in addition to conventional Western medicine. According to the National Centre for Complementary and Integrative Health, CAM includes a wide range of non-conventional health practices and products such as dietary supplements, meditation, and chiropractic
0 Comments
PLAINSBORO, N.J., Dec. 4, 2020 /PRNewswire/ – Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved an updated label for Saxenda® (liraglutide) injection 3 mg for use in the treatment of obesity in adolescents (12–17 years) with a body weight above 60 kg and an initial body mass index (BMI) corresponding to 30 kg/m2 or greater
0 Comments
With the rapid emergence and spread of COVID-19, governments and public health authorities have introduced several non-pharmaceutical measures to slow the spread and reduce infection rates. Recently published in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS), scientists analyzed reported cases of the spread of COVID-19 at various event
0 Comments
What effect do cocoa flavanols have on the brain? Bad news has been plentiful in the year 2020. However, as the year draws to a close, a new study published in the journal Nature Scientific Reports, may provide some much needed good news. Is chocolate actually good for your brain (1)? The study examines the
0 Comments
Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Supernus Provides Regulatory Update for SPN-812 ROCKVILLE, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced a regulatory update for SPN-812 (viloxazine hydrochloride) for the
0 Comments
FDA Approves Orladeyo (berotralstat) as the First Oral, Once-Daily Therapy to Prevent Attacks in Hereditary Angioedema Patients RESEARCH TRIANGLE PARK, N.C., Dec. 03, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the U.S. Food and Drug Administration (FDA) has approved oral, once-daily Orladeyo (berotralstat) for prophylaxis to prevent attacks of hereditary
0 Comments
Researchers at the University of Vermont have developed a model to gauge the safety of open schools. Reopening schools during the COVID-19 pandemic has been a topic of much debate and concern. Prolonged school closures may have lasting effects on child health and development. Many working or disadvantaged parents and caregivers rely on school systems
0 Comments
A recently published review uses various studies to look into the effect of vitamin E on stroke risk. Globally, 55 million people die from a stroke every year. There are two different types of stroke, ischaemic and haemorrhagic, where either blood is blocked from the brain, or bleeding occurs in the brain. As the proportion
0 Comments
Treatment for Opioid Overdose Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding Zimhi SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) today announced that after the close of business and the U.S. markets on November 13th, it received a Complete Response Letter (CRL) from the U.S.
0 Comments
South San Francisco, CA — December 1, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Gavreto™ (pralsetinib) for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic rearranged during
0 Comments
pegcetacoplan Treatment for Paroxysmal Nocturnal Hemoglobinuria Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of PNH WALTHAM, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) – Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the U.S. Food and Drug Administration (FDA)
0 Comments
Treatment for Schizophrenia, Bipolar Disorder Alkermes Receives FDA Complete Response Letter Related to ALKS 3831 Manufacturing Records Review DUBLIN, Nov. 17, 2020 /PRNewswire/ – Alkermes plc (Nasdaq: ALKS) today announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ALKS 3831 (olanzapine/samidorphan) for the treatment of adults
0 Comments
New research study shows how everyday physical activities, such as climbing stairs, can improve personal well-being. The benefits of physical activity on physical and mental health are well known. However, the different subtypes of physical activity are not always considered. Exercise activities are structured physical activities that are done over a prolonged time and require
0 Comments
Treatment for Prevention of Catheter Related Blood Stream Infections (CRBSI) CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not Needed Berkeley Heights, NJ – November 18, 2020 – CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of
0 Comments
News FDA Alerts FDA Alerts Healthcare Professionals About the Risk of Medication Errors with Tranexamic Acid Injection Resulting in Inadvertent Intrathecal (Spinal) Injection December 3, 2020 Audience: Healthcare Professionals December 3, 2020 — The U.S. Food and Drug Administration is alerting health care professionals about the risk of inadvertent intrathecal administration of tranexamic acid injection.
0 Comments
New guidelines on recommended physical activity consider ways to potentially counter the health risks associated with a sedentary lifestyle. It is no secret that regularly getting physical activity is healthy for the body.  Exercise can have a variety of physical health benefits; it can promote heart health, muscle development and maintenance, bone density, maintenance of
0 Comments